HZNP Horizon Pharma Plc

Horizon Pharma PLC is a pharmaceutical company. The company focuses on identifying, developing, and commercializing of differentiated and accessible medicines to address unmet medical needs mainly in the US.

$85.14  +2.23 (2.69%)
As of 06/24/2022 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  Ireland
IPO date:  07/28/2011
Outstanding shares:  229,884,077
Average volume:  2,021,456
Market cap:   $19,059,688,824
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BQPVQZ6
Valuation   (See tab for details)
PE ratio:   22.70
PB ratio:   4.06
PS ratio:   5.06
Return on equity:   17.89%
Net income %:   22.87%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy